影像组学特征与临床生物标志物联合模型列线图鉴别非进展性与进展性肝纤维化的回顾性研究
联合模型在训练集和测试集的AUC分别为0.915和0.897,敏感度86%和80.6%,特异度82.6%和92.3%。决策曲线分析提示列线图具有临床应用潜力。
要点
- 联合模型鉴别非进展性与进展性肝纤维化的AUC在训练集为0.915、测试集为0.897,优于单纯影像组学模型。
- 联合模型测试集特异度92.3%、敏感度80.6%,训练集特异度82.6%、敏感度86%。
- 列线图整合影像组学特征与临床生物标志物,决策曲线提示临床有用。
核心结论
- 影像组学特征与临床生物标志物联合模型及列线图对鉴别非进展性与进展性肝纤维化有较好区分度与校准度。
研究设计与样本
- 从门静脉期CT图像提取1674个影像组学特征,经最小冗余最大相关降维筛选最优特征。
- 评估8个临床标志物,结合临床独立危险因素构建联合模型并建立列线图,以病理诊断为参考标准。
诊断标准与关键数值
- 影像组学模型训练集AUC 0.864、准确率77.8%、敏感度86.7%、特异度71.4%,测试集AUC 0.772、准确率77.8%、敏感度73.1%、特异度90.0%。
- 联合模型训练集AUC 0.915、准确率83.3%、敏感度86%、特异度82.6%,测试集AUC 0.897、准确率86.1%、敏感度80.6%、特异度92.3%。
临床应用与阅片要点
- 可基于门静脉期CT提取的影像组学特征联合临床生物标志物,用列线图辅助鉴别非进展性与进展性肝纤维化。
- 联合模型较单纯影像组学模型有更高的AUC和特异度,测试集特异度达92.3%,有助于减少误判。
局限性
- 原文未报告影像组学特征的具体名称和列线图具体评分阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and validate a combination model of radiomics features and clinical biomarkers to differentiate nonadvanced from advanced liver fibrosis.
MATERIALS AND METHODS: One hundred and eight consecutive patients with pathologically diagnosed liver fibrosis were randomly placed in a training or a test cohort at a ratio of 2:1. For each patient, 1674 radiomics features extracted from portal venous phase CT images were reduced by using minimum redundancy and maximum relevant. The optimal features identified were incorporated into the radiomics model. Eight clinical markers were evaluated. Integrated with clinical independent risk factors, a combination model was built. A nomogram was also established from the model. The performance of the models was assessed. Finally, a decision curve analysis was performed to estimate the clinical usefulness of the nomogram.
RESULTS: The radiomics model established using five features achieved a promising level of discrimination between nonadvanced and advanced liver fibrosis. The combination model incorporated the radiomics signature with two clinical biomarkers and showed good calibration and discrimination. The training and testing cohort results of the radiomics model were area under curve values 0.864 and 0.772, accuracy 77.8% and 77.8%, sensitivity 86.7% and 73.1%, and specificity 71.4% and 90.0%, respectively. For the combination model, the training and testing cohort results were area under curve values 0.915 and 0.897, accuracy 83.3% and 86.1%, sensitivity 86% and 80.6%, and specificity 82.6% and 92.3%, respectively. The decision curve indicated the nomogram has potential in clinical application.
CONCLUSION: This combination model provides a promising approach for differentiating non-advanced from advanced liver fibrosis.
引用
- Hu P, Hu X, Lin Y, et al. A Combination Model of Radiomics Features and Clinical Biomarkers as a Nomogram to Differentiate Nonadvanced From Advanced Liver Fibrosis: A Retrospective Study. Acad Radiol. 2021. PMID: 34023199. doi:10.1016/j.acra.2020.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。